These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19821820)

  • 1. Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression.
    Bogner C; Dechow T; Ringshausen I; Wagner M; Oelsner M; Lutzny G; Licht T; Peschel C; Pastan I; Kreitman RJ; Decker T
    Br J Haematol; 2010 Jan; 148(1):99-109. PubMed ID: 19821820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion.
    Biberacher V; Decker T; Oelsner M; Wagner M; Bogner C; Schmidt B; Kreitman RJ; Peschel C; Pastan I; Meyer Zum Büschenfelde C; Ringshausen I
    Haematologica; 2012 May; 97(5):771-9. PubMed ID: 22180432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents.
    Touzeau C; Dousset C; Bodet L; Gomez-Bougie P; Bonnaud S; Moreau A; Moreau P; Pellat-Deceunynck C; Amiot M; Le Gouill S
    Clin Cancer Res; 2011 Sep; 17(18):5973-81. PubMed ID: 21821698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses in mantle cell lymphoma cells to SNS-032 depend on the biological context of each cell line.
    Chen R; Chubb S; Cheng T; Hawtin RE; Gandhi V; Plunkett W
    Cancer Res; 2010 Aug; 70(16):6587-97. PubMed ID: 20663900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells.
    Bogner C; Ringshausen I; Schneller F; Fend F; Quintanilla-Martinez L; Häcker G; Goetze K; Oostendorp R; Peschel C; Decker T
    Br J Haematol; 2003 Jul; 122(2):260-8. PubMed ID: 12846895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins.
    Decker T; Oelsner M; Kreitman RJ; Salvatore G; Wang QC; Pastan I; Peschel C; Licht T
    Blood; 2004 Apr; 103(7):2718-26. PubMed ID: 14525789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK.
    Brosseau C; Dousset C; Touzeau C; Maïga S; Moreau P; Amiot M; Le Gouill S; Pellat-Deceunynck C
    Cell Death Dis; 2014 Aug; 5(8):e1389. PubMed ID: 25165875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Signal Transducer and Activator of Transcription 5B (STAT5B) Gene Promotes Proliferation and Drug Resistance of Human Mantle Cell Lymphoma Cells by Activating the Akt Signaling Pathway.
    Zhang W; Liang X; Gong Y; Xiao C; Guo B; Yang T
    Med Sci Monit; 2019 Apr; 25():2599-2608. PubMed ID: 30964854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphoma.
    Jin L; Tabe Y; Kimura S; Zhou Y; Kuroda J; Asou H; Inaba T; Konopleva M; Andreeff M; Miida T
    Br J Cancer; 2011 Jan; 104(1):91-100. PubMed ID: 21139584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status.
    Pérez-Galán P; Roué G; Villamor N; Montserrat E; Campo E; Colomer D
    Blood; 2006 Jan; 107(1):257-64. PubMed ID: 16166592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bruton tyrosine kinase is commonly overexpressed in mantle cell lymphoma and its attenuation by Ibrutinib induces apoptosis.
    Cinar M; Hamedani F; Mo Z; Cinar B; Amin HM; Alkan S
    Leuk Res; 2013 Oct; 37(10):1271-7. PubMed ID: 23962569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak.
    Pérez-Galán P; Roué G; Villamor N; Campo E; Colomer D
    Blood; 2007 May; 109(10):4441-9. PubMed ID: 17227835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
    Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
    Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 4 mantle cell lymphoma cell lines.
    Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
    Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
    Montraveta A; Xargay-Torrent S; Rosich L; López-Guerra M; Roldán J; Rodríguez V; Lee-Vergés E; de Frías M; Campàs C; Campo E; Roué G; Colomer D
    Oncotarget; 2015 Aug; 6(25):21159-72. PubMed ID: 26110568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma.
    Knapp CM; He J; Lister J; Whitehead KA
    Exp Biol Med (Maywood); 2016 May; 241(9):1007-13. PubMed ID: 27022142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism.
    Gelebart P; Zak Z; Anand M; Dien-Bard J; Amin HM; Lai R
    Leukemia; 2009 Oct; 23(10):1836-46. PubMed ID: 19494838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered apoptosis pathways in mantle cell lymphoma.
    Rummel MJ; de Vos S; Hoelzer D; Koeffler HP; Hofmann WK
    Leuk Lymphoma; 2004 Jan; 45(1):49-54. PubMed ID: 15061196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib.
    Sun B; Shah B; Fiskus W; Qi J; Rajapakshe K; Coarfa C; Li L; Devaraj SG; Sharma S; Zhang L; Wang ML; Saenz DT; Krieger S; Bradner JE; Bhalla KN
    Blood; 2015 Sep; 126(13):1565-74. PubMed ID: 26254443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal
    Prukova D; Andera L; Nahacka Z; Karolova J; Svaton M; Klanova M; Havranek O; Soukup J; Svobodova K; Zemanova Z; Tuskova D; Pokorna E; Helman K; Forsterova K; Pacheco-Blanco M; Vockova P; Berkova A; Fronkova E; Trneny M; Klener P
    Clin Cancer Res; 2019 Jul; 25(14):4455-4465. PubMed ID: 31004002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.